Altitude Crest Partners’s Ambrx Biopharma Inc AMAM Stock Holding History

Altitude Crest Partners’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-43,100	Closed	-$614K	–	34
2023 Q4	$614K	Buy	+43,100	New	+$490K	0.41%	11

Altitude Crest Partners's AMAM Position: Q1 2024 in Review

Altitude Crest Partners sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 43,100 shares — an estimated $614K sold.

Altitude Crest Partners first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $614K in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Altitude Crest Partners reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Altitude Crest Partners sold 43,100 Ambrx Biopharma Inc shares in Q1 2024, an estimated $614K.
Altitude Crest Partners first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
Altitude Crest Partners's Ambrx Biopharma Inc position peaked at $614K in Q4 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Altitude Crest Partners's 13F filing for Q1 2024, filed 14 May 2024.